Skip to main content

FDA recall, , Moderate risk

Shimadzu Trinias Opera Smart, Opera Grand and Smart OBL Interventional Fluoroscopic X-Ray Systems

The mounting bolts securing the C-arm drive unit may not be torqued to specification.

SHIMADZU CORPORATION MEDICAL SYSTEMS DIVISION began this recall on Sep 30, 2025. FDA posted it on Nov 3, 2026; it is still open. Still check yours.

What happened

SHIMADZU CORPORATION MEDICAL SYSTEMS DIVISION of Kyoto, Japan, voluntarily initiated a recall of its Trinias Opera Smart (C16s, F12s)/Opera Grand(C12s,C16s, F12s)/Smart OBL Interventional Fluoroscopic X-Ray System containing C-arm support (MH-500, MH-60).

The mounting bolts securing the C-arm drive unit of the X-ray system may not be torqued to specification, potentially compromising structural stability and safe operation. The recall was added to the FDA's Enforcement Report and classified on November 3, 2026.

The recall began on September 30, 2025, and customers were notified by e-mail. The product was distributed nationwide in the states of SC, TX, FL, TN, CA, FL, and NY.

What to do

The FDA notice gives no instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Match the UDI-DI and other code listed under your product.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Trinias Opera Smart (C16s, F12s)/Opera Grand(C12s,C16s, F12s)/Smart OBL Interventional Fluoroscopic X-Ray System containing C-arm support (MH-500, MH-60),

    UDI-DI
    • 04540217067145
    Other code
    • M1F0D3BF4001
    • SMS20250167
    • 250

Recall details

Posted by FDA
Recall began
Status
Open
Sold in

US Nationwide distribution in the states of South Carolina, Texas, Florida, Tennessee, California, Florida, New York.

Recalled by
SHIMADZU CORPORATION MEDICAL SYSTEMS DIVISIONKyoto, Japan
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

FDA event number
100044
Recall number
Z-0347-2027
Quantity recalled
118 unts.
Recall type
Voluntary: Firm initiated
How the company first told customers
E-Mail

All recalls from SHIMADZU CORPORATION MEDICAL SYSTEMS DIVISION

Timeline

FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.

  1. SHIMADZU CORPORATION MEDICAL SYSTEMS DIVISION began the recall

  2. FDA posted the recall to its Enforcement Report and rated it Class II (moderate risk)

  3. Added to Recall Canary

Summary by Recall Canary, written with AI · summary updated Nov 4, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)